STEVE ELMS - 12 Feb 2025 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role: Director
Signature: /s/ Julio C. Esquivel, as Attorney-in-Fact for Steve Elms
Issuer symbol: MRKR
Transactions as of: 12 Feb 2025
Transactions value $: $0
Form type: 4
Filing time: 14 Feb 2025, 17:20:34 UTC
Previous filing: 26 Dec 2024
Next filing: 21 Feb 2025
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRKR	Stock Option (right to buy)	Award	$0	+30,000		$0	30,000	12 Feb 2025	Common Stock	30,000	$1.59	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents options granted under the Company's 2020 Omnibus Stock Ownership Plan. One third of the shares vest on the first anniversary of the grant date and the remainder of the shares subsequently vest in equal annual installments over the second and third anniversary of the grant date subject to the Reporting Person's continued service as a director. The option exercise price is the closing price on the date of the grant, February 12, 2025.

Content

Represents options granted under the Company's 2020 Omnibus Stock Ownership Plan. One third of the shares vest on the first anniversary of the grant date and the remainder of the shares subsequently vest in equal annual installments over the second and third anniversary of the grant date subject to the Reporting Person's continued service as a director. The option exercise price is the closing price on the date of the grant, February 12, 2025.